Vir Biotechnology, Inc.·4

Feb 22, 5:02 PM ET

Virgin Herbert 4

4 · Vir Biotechnology, Inc. · Filed Feb 22, 2022

Insider Transaction Report

Form 4
Period: 2022-02-17
Virgin Herbert
EVP, Research & CSO
Transactions
  • Sale

    Common Stock

    2022-02-17$31.93/sh2,293$73,218105,407 total
Footnotes (1)
  • [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION